(Q39651481)

English

Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis

scientific article published on April 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis (English)

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

cystic fibrosis

0 references

Pseudomonas aeruginosa

0 references

0 references

Stenotrophomonas maltophilia

1 reference

based on heuristic

inferred from title

Burkholderia cepacia

1 reference

based on heuristic

inferred from title

Alcaligenes xylosoxidans

object named as

Alcaligenes xylosoxidans

1 reference

based on heuristic

inferred from title

author name string

Lisa Saiman

1

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Yunhua Chen

2

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Pablo San Gabriel

3

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Charles Knirsch

4

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

46

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

4

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

1105-1107

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

14 September 2017

Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

14 September 2017

Evaluation of reference dilution test methods for antimicrobial susceptibility testing of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

14 September 2017

Direct evidence for antipseudomonal activity of macrolides: exposure-dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

14 September 2017

Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

14 September 2017

Microbiology of airway disease in patients with cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

14 September 2017

A Review of the Recent Progress in Treatment of Patients with Diffuse Panbronchiolitis Associated with Pseudomonas aeruginosa Infection in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

14 September 2017

Management of pulmonary disease in patients with cystic fibrosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

25 September 2017

Inhibition of Pseudomonas aeruginosa virulence factors by subinhibitory concentrations of azithromycin and other macrolide antibiotics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

25 September 2017

Microbiology of sputum from patients at cystic fibrosis centers in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

17 June 2018

Biofilm disease: its clinical manifestation and therapeutic possibilities of macrolides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=127106

21 August 2018

Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The changing epidemiology of cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diffuse panbronchiolitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In-vitro effects of antimicrobial agents on Pseudomonas aeruginosa biofilm formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect on Pseudomonas aeruginosa alginate expression of direct plating and culture of fresh cystic fibrosis sputum on to pseudomonas isolation agar containing subinhibitory concentrations of roxithromycin and rifampicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibiotic susceptibility of multiply resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis, including candidates for transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibitory activity of clarithromycin on biofilm synthesis with Pseudomonas aeruginosa

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term azithromycin may improve lung function in children with cystic fibrosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-inflammatory activity of macrolides: a new therapeutic potential?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11897598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.46.4.1105-1107.2002

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39651481&oldid=2173778056"